Novo Nordisk Group

Novo Nordisk Group is a global healthcare company with a rich history and a strong commitment to improving the lives of people with chronic diseases. Founded in 1923, the company has grown to become a leader in diabetes care, producing innovative insulin products and devices that help millions manage their condition effectively.

In addition to diabetes, Novo Nordisk is dedicated to addressing other serious health issues such as obesity, haemophilia, and growth disorders. The company invests heavily in research and development, striving to bring new therapies to market that can transform patient outcomes.

Novo Nordisk operates in more than 80 countries and markets its products in over 170 countries worldwide. The company’s headquarters are located in Denmark, but it has a significant presence in the UK, where it collaborates with healthcare professionals and institutions to enhance patient care.

Core Values and Vision

• Innovation: Continuously seeking new solutions to improve treatment options.
• Quality: Ensuring the highest standards in product development and manufacturing.
• Responsibility: Committed to sustainable practices and corporate social responsibility.
• Collaboration: Working together with stakeholders to achieve common goals in healthcare.

The vision of Novo Nordisk is to drive change in diabetes care and beyond, aiming for a world where chronic diseases are managed effectively, allowing individuals to lead healthier lives. With a focus on patient-centric approaches, the company prioritises understanding the needs of patients and healthcare providers alike.

As a pioneer in the biopharmaceutical industry, Novo Nordisk continues to set benchmarks for excellence, making significant contributions to global health and well-being. Through its dedication to innovation and quality, Novo Nordisk remains at the forefront of transforming healthcare for future generations.